Literature DB >> 8355728

Quantifying how location and dose of botulinum toxin injections affect muscle paralysis.

C M Shaari1, I Sanders.   

Abstract

Despite the widespread use of botulinum toxin to treat muscle dystonias, no method exists to quantify muscle paralysis in either human or nonhuman models. In this study we examined how the location, dose, and volume of botulinum injection affects paralysis in the rat tibialis anterior muscle. Paralysis was quantified by electrically stimulating the nerve to the tibialis anterior and then staining sections of the muscle for glycogen. The areas of glycogen-containing fibers represented regions of botulinum action. The results showed that the most important injection technique is to inject botulinum directly into the motor endplate region of a muscle. Injections only 0.5 cm from the motor endplate resulted in a 50% decrease in paralysis. Increases in dose increased paralysis, however, some of that increase was simply due to the increased volume of injection. Thus, delivering toxin in small volumes near the MEP band of a muscle should produce the most effective paralysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8355728     DOI: 10.1002/mus.880160913

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  32 in total

1.  [Botulinum toxin in the treatment of adult spasticity. An interdisciplinary German 10-point consensus 2010].

Authors:  J Wissel; M auf dem Brinke; M Hecht; C Herrmann; M Huber; S Mehnert; I Reuter; A Schramm; A Stenner; C van der Ven; M Winterholler; A Kupsch
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

2.  Extra- and intramuscular nerve supply of the muscles of the anterior antebrachial compartment: applications for selective neurotomy and for botulinum toxin injection.

Authors:  D Lepage; B Parratte; L Tatu; F Vuiller; G Monnier
Journal:  Surg Radiol Anat       Date:  2005-11-25       Impact factor: 1.246

Review 3.  [Botulinum toxin therapy in orthopaedics].

Authors:  L Döderlein
Journal:  Orthopade       Date:  2006-01       Impact factor: 1.087

4.  Muscle fiber orientation in muscles commonly injected with botulinum toxin: an anatomical pilot study.

Authors:  S Deshpande; M E Gormley; J R Carey
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 5.  Botulinum toxin treatment of children with cerebral palsy - a short review of different injection techniques.

Authors:  A S Schroeder; S Berweck; S H Lee; F Heinen
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

Review 6.  The treatment of cervical dystonia with botulinum toxins.

Authors:  C L Comella
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

Review 7.  Botulinum toxin for pain.

Authors:  Roberto Casale; Valeria Tugnoli
Journal:  Drugs R D       Date:  2008

8.  Localization of motor entry points and terminal intramuscular nerve endings of the musculocutaneous nerve to biceps and brachialis muscles.

Authors:  Je-Hun Lee; Hye-Won Kim; Sun Im; Xiaochun An; Mi-Sun Lee; U-Young Lee; Seung-Ho Han
Journal:  Surg Radiol Anat       Date:  2009-09-25       Impact factor: 1.246

Review 9.  Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases.

Authors:  S Jitpimolmard; S Tiamkao; M Laopaiboon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-06       Impact factor: 10.154

10.  Treatment of chronic limb spasticity with botulinum toxin A.

Authors:  J W Dunne; N Heye; S L Dunne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.